AI Summary
✦ ClarthaValuation Metrics
Trading 122.2% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.85). Confidence: 63%.
Live forward EPS implies next-12-month EPS of ₹15.86. Applying the stock's normalized valuation corridor produces a fair range of ₹291.67 to ₹575.24, with base value near ₹415.69 (-35.3% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹15.86
Forward P/E
40.5x
Base Fair Value
₹415.69
Fair Range
₹291.67 - ₹575.24
Upside To Base
-35.3%
Estimate Source
Live forward EPS
Growth Estimate
+31.8%
5Y Average
25.48
Current
58.24
Overvalued
36.27
Undervalued
18.39
5Y Average
17.07
Current
39.02
Overvalued
20.70
Undervalued
11.60
5Y Average
5.11
Current
11.68
Overvalued
6.20
Undervalued
3.47
Peers & Comparison
Sector: Health Care · Theme: Hospitals & Diagnostic Centres
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
RAINBOW CHILDRENS MED LTD RAINBOWHospitals & Diagnostic Centres | +33.2% | 15.7% | 52.6x Undervalued | -25% vs avg | -2.8% |
PARK MEDI WORLD LIMITED PARKHOSPSHospitals & Diagnostic Centres | +19.3% | 16.1% | 43.2x Undervalued | -38% vs avg | +91.0% |
METROPOLIS HEALTHCARE LTD METROPOLISHospitals & Diagnostic Centres | +16.6% | 11.8% | 56.7x Undervalued | -19% vs avg | +6.6% |
JUPITER LIFE LINE HOSP L JLHLHospitals & Diagnostic Centres | +18.2% | 12.0% | 53.5x Undervalued | -24% vs avg | +7.8% |
NEPHROCARE HEALTH SERV L NEPHROPLUSHospitals & Diagnostic Centres | +22.2% | 8.1% | 83.6x Premium | +19% vs avg | +51.2% |
NARAYANA HRUDAYALAYA LTD. NHHospitals & Diagnostic Centres | +80.4% | 9.0% | 45.2x Undervalued | -36% vs avg | +1.0% |
GLOBAL HEALTH LIMITED MEDANTAHospitals & Diagnostic Centres | +26.5% | 11.9% | 67.6x Fair | -4% vs avg | +6.3% |
KRISHNA INST OF MED SCI L KIMSHospitals & Diagnostic Centres | +35.3% | 4.8% | 158.3x Premium | +126% vs avg | +11.2% |
THYROCARE TECH LTD trades at a discount (58.2x vs peer avg 70.1x), suggesting potential undervaluation relative to the Hospitals & Diagnostic Centres cohort. Peers include RAINBOW CHILDRENS MED LTD, PARK MEDI WORLD LIMITED, METROPOLIS HEALTHCARE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.